Lakeland Bancorp Inc. (NASDAQ:LBAI) shares moved up 2.09% in last trading session and ended the day at $10.75. LBAI has a return on assets of 0.90%. Lakeland Bancorp Inc. (NASDAQ:LBAI) quarterly performance is -5.19%.
Lakeland Bancorp Inc. (NASDAQ:LBAI) target price was lowered by Raymond James. The stock’s target price was lowered, and went from $13.00 to $12.00
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) caters to the Healthcare space. Its weekly performance is -0.93%. On the last day of trading company shares ended up at $6.42. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) distance from 50-day simple moving average (SMA50) is 29.01%.
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) announced that John A. McCarthy, Jr. has decided not to stand for re-election to the Board of Directors at the Company’s 2016 Annual Meeting of the Stockholders. Mr. McCarthy is departing to devote more time to his role as Chief Executive Officer and a director of ZS Genetics, Inc. as well as his other business ventures. Mr. McCarthy will continue to serve as a director of the Company until the expiration of his term at the conclusion of the Company’s 2016 Annual Meeting of Stockholders.
On 13 April, Harman International Industries, Incorporated (NYSE:HAR) shares moved up 4.73% and was closed at $83.92. HAR EPS growth in last 5 year was 57.50%. Harman International Industries, Incorporated (NYSE:HAR) year to date (YTD) performance is -10.48%.
On 3 April, Harman International Industries, Incorporated (NYSE:HAR) provides an overview of the Hemispherx Biopharma, Inc ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemispherx Biopharma, Inc, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemispherx Biopharma, Inc and special features on late-stage and discontinued projects.
Pfizer Inc. (NYSE:PFE) shares moved up 1.81% in last trading session and ended the day at $32.54. PFE Gross Margin is 80.40% and its has a return on assets of 5.70%. Pfizer Inc. (NYSE:PFE) quarterly performance is 6.02%.
Pfizer Inc. (NYSE:PFE) said that, it is aiming to have a sensor-enabled remote patient monitoring system in place by 2019. The Big Pharma has teamed up with IBM ($IBM) for the project, which will construct a sensor-laden connected house to test the concept ahead of its planned use in a Phase III Parkinson’s disease trial in 2019.
Solazyme, Inc. (NASDAQ:SZYM) caters to the Basic Materials space. Its weekly performance is -0.48%. On the last day of trading company shares ended up at $2.07. Solazyme, Inc. (NASDAQ:SZYM) distance from 50-day simple moving average (SMA50) is 0.94%.
On 5 April, Solazyme, Inc. (NASDAQ:SZYM) said that, It’s a new name and a consolidated vision for microalgae firm Solazyme (San Francisco), which is changing its name to TerraVia to reflect “a new focus on food, nutrition, and specialty ingredients.” Other business areas the company has invested in, such as fuels and industrial oils, will not be part of TerraVia’s portfolio.
Leave a Reply